TRLV
Trulieve Cannabis Corp ( Delaware )
NEW YORK STOCK EXCHANGE, INC.· Pharmaceuticals· US· IPO 2018-09-25
$11.54
+0.44 (+3.96%)
last quote
Want the full multi-source brief on TRLV?
The agent pulls regulatory filings, news flow, prediction-market pricing, and macro context — then synthesizes what's not yet in the price.
Today
Open
$11.54
High
$12.00
Low
$11.25
Previous close
$11.10
Fundamentals
Market cap
$2.20B
P/E (TTM)
—
P/S (TTM)
1.93x
P/B
—
Gross margin
59.47%
Operating margin
-24.49%
Net margin
-41.55%
Rev growth (YoY)
-3.90%
EPS growth (YoY)
—
ROE
-44.03%
52W high
$12.93
52W low
$7.82
Beta
0.43x
Industry peers
by market cap
Upcoming earnings
next 30 days
2026-11-05todaybefore market
Q3 2026EPS est $0.07Rev est $226.3M
Recent SEC filings
CIK 1754195filing-language history →
Recent news
2026-10-28 → 2026-11-04
Yahoo · 1d
What Just Happened With Trulieve Cannabis (TRLV) Shares?
Trulieve Cannabis (TRLV) just confirmed it secured Drug Enforcement Administration registrations for its state-licensed medical marijuana dispensaries, following the federal move to classify qualifying medical cannabis as Schedule III under the Controlled Substances Act. The DEA registrations come at a time when Trulieve Cannabis has already seen positive momentum, with a 1-day share price return
Yahoo · 1d
Trulieve Receives DEA Registrations for State-Licensed Medical Marijuana Operations
Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., today announced that Trulieve has received registrations for medical marijuana dispensaries as part of the initial registrations issued by the U.S. Drug Enforcement Administration (DEA). On Friday, the DEA announced it has begun the initial issuance of federal regi
Benzinga · 1d
Cantor Fitzgerald Reiterates Overweight on Trulieve Cannabis, Maintains $15 Price Target
Cantor Fitzgerald analyst Gabie Ingoglia reiterates Trulieve Cannabis (NYSE:TRLV) with a Overweight and maintains $15 price target.
Benzinga · 2d
Trulieve Cannabis Awarded Registrations For Medical Marijuana Dispensaries From U.S. Drug Enforcement Administration
Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., today announced that Trulieve has received registrations for medical
This is the free preview
The agent layer adds regulatory-language drift detection, cross-venue prediction-market signals, macro overlays, programmable alert rules, overnight briefs, and a grounding verifier on every claim. 7-day Pro trial, no card required.
Start the trial